Literature DB >> 367963

Treatment of rheumatoid and degenerative diseases with copper complexes: a review with emphasis on copper-salicylate.

J R Sorenson, W Hangarter.   

Abstract

This review presents a historical account of the treatment of rheumatoid and other degenerative diseases with copper complexes. Clinical data obtained from 1940 to 1971 are provided for about 1,500 patients with rheumatoid arthritis (acute or chronic), rheumatic fever, ankylosing spondylitis, staphlococcal spondylitis, gonococcal arthritis, chronic gouty arthritis, polyarticular synovitis, coxitis, disseminated spondylitis, arthritis with psoriasis, Reiter's syndrome, lupus erythematosus, sarcoidosis, arthrosis deformans, erythema nodosum, sciatica (with and without lumbar involvement), cervical spine-shoulder syndrome or lumbar spine syndrome. The drugs used in these studies were Dicuprene, Alcuprin, Cuprimyl, and Permalon, a copper-salicylate preparation. A detailed presentation of toxicities associated with the use of these copper complexes is included.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 367963     DOI: 10.1007/bf00917597

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  12 in total

1.  Treatment of rheumatoid arthritis with organic copper compounds.

Authors:  T J O'REILLY
Journal:  Br Med J       Date:  1955-01-15

2.  [Therapy of inflammatory articular rheumatism].

Authors:  M BROGLIE
Journal:  Dtsch Med Wochenschr       Date:  1954-05-07       Impact factor: 0.628

3.  Studies on the function and metabolism of copper.

Authors:  M M WINTROBE; G E CARTWRIGHT; C J GUBLER
Journal:  J Nutr       Date:  1953-08       Impact factor: 4.798

4.  [The chronic primary polyarthritis and its treatment].

Authors:  W H FAHNDRICH
Journal:  Medizinische       Date:  1952-11-15

5.  Copper treatment of experimental and clinical arthritis.

Authors:  W C KUZELL; R W SCHAFFARZICK; E A MANKLE; G M GARDNER; D M FAIRLEY; P S TABAR
Journal:  Ann Rheum Dis       Date:  1951-09       Impact factor: 19.103

6.  Therapeutic criteria in rheumatoid arthritis.

Authors:  O STEINBROCKER; C H TRAEGER; R C BATTERMAN
Journal:  J Am Med Assoc       Date:  1949-06-25

7.  Copper and Gold Salts in Rheumatoid Arthritis.

Authors:  J Forestier
Journal:  Ann Rheum Dis       Date:  1949-06       Impact factor: 19.103

8.  [Therapy of rheumatic diseases with a copper-sodium salicylate complex compound (permalon)].

Authors:  W HANGARTER; A LUBKE
Journal:  Dtsch Med Wochenschr       Date:  1952-07-04       Impact factor: 0.628

9.  Copper therapy of rheumatoid arthritis.

Authors:  T L TYSON; H H HOLMES; C RAGAN
Journal:  Am J Med Sci       Date:  1950-10       Impact factor: 2.378

10.  Some copper coordination compounds and their antiinflammatory and antiulcer activities.

Authors:  J R Sorenson
Journal:  Inflammation       Date:  1976-06       Impact factor: 4.092

View more
  9 in total

1.  Copper complexes of non-steroidal antiinflammatory agents: analgesic activity and possible opioid receptor activation.

Authors:  S Okuyama; S Hashimoto; H Aihara; W M Willingham; J R Sorenson
Journal:  Agents Actions       Date:  1987-06

2.  The pharmacologic activity of complexes and mixtures with copper and salicylates or aminopyrine following oral dosing in rats.

Authors:  Z Korolkiewicz; E Hać; I Gagało; P Gorczyca; A Lodzińska
Journal:  Agents Actions       Date:  1989-03

Review 3.  The role of copper in inflammatory disorders.

Authors:  A J Lewis
Journal:  Agents Actions       Date:  1984-12

4.  Serum copper: a marker of disease activity in rheumatoid arthritis.

Authors:  A A Youssef; B Wood; D N Baron
Journal:  J Clin Pathol       Date:  1983-01       Impact factor: 3.411

5.  A comparison of therapies which may influence trace metals in rheumatoid arthritis.

Authors:  J S Dixon; H A Bird; K E Surrall; N G Sitton; V Wright
Journal:  Clin Rheumatol       Date:  1984-12       Impact factor: 2.980

6.  Pharmacologic activities of copper compounds in chronic diseases.

Authors:  J R Sorenson; L W Oberley; R K Crouch; T W Kensler; V Kishore; S W Leuthauser; T D Oberley; A Pezeshk
Journal:  Biol Trace Elem Res       Date:  1983-08       Impact factor: 3.738

7.  Anti-inflammatory activity of a dermally applied copper salicylate preparation (Alcusal).

Authors:  W R Walker; S J Beveridge; M W Whitehouse
Journal:  Agents Actions       Date:  1980-04

8.  Modulation of polymorphonuclear leukocyte responsiveness by copper (II)2 (niflumate)4.

Authors:  M Roch-Arveiller; L Maman; D P Huy; J Fontagne; J P Giroud; J R Sorenson
Journal:  Inflamm Res       Date:  1995-05       Impact factor: 4.575

9.  Effect of cuprofilin on experimental atherosclerosis.

Authors:  M Vlad; E Bordas; E Caseanu; G Uza; E Creteanu; C Polinicenco
Journal:  Biol Trace Elem Res       Date:  1995-04       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.